Načítá se...
Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy
Background and study aims: Current guidelines recommend using endoscopic ultrasound (EUS), carcinoembryonic antigen (CEA) testing and cytology to manage incidental pancreatic cystic neoplasms (PCN); however, studies suggest a strategy including integrated molecular pathology (IMP) of cyst fluid may...
Uloženo v:
| Vydáno v: | Endosc Int Open |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
© Georg Thieme Verlag KG
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4612224/ https://ncbi.nlm.nih.gov/pubmed/26528505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0034-1392016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|